Literature DB >> 2471710

The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects.

T Spinder1, J J Spijkstra, J G van den Tweel, C W Burger, H van Kessel, P G Hompes, L J Gooren.   

Abstract

Polycystic ovarian disease (PCOD) is associated with elevated serum LH and (sub)normal FSH levels, while serum androgen levels are often elevated. To clarify the role of androgens in this abnormal pattern of gonadotropin secretion, LH secretion was studied in 1) 9 eugonadal female to male transsexual subjects before and during long term (6 months) testosterone (T) administration (250 mg/2 weeks, im), and 2) in a woman with an androgen-secreting ovarian tumor both before and after surgical removal of the tumor. Finally, we studied the effects of high serum androgen levels on ovarian histology in 3) 26 transsexual subjects after long term (9-36 months) T administration (250 mg/2 weeks, im) to assess whether T-induced ovarian abnormalities are similar to those that occur in women with PCOD. Long term T treatment in the nine female to male transsexual subjects resulted in increases in the mean serum T level from 1.7 +/- 0.8 (+/- SD) to 40.8 +/- 31.9 nmol/L (P less than 0.01), the mean serum dihydrotestosterone level from 0.6 +/- 0.2 to 3.3 +/- 1.5 nmol/L (P less than 0.02), and the mean serum free T level from 9.5 +/- 5.2 to 149 +/- 46 pmol/L (P less than 0.02). Mean serum estrone and estradiol levels were similar before and during T treatment. The mean serum LH level decreased from 6.3 +/- 2.0 to 2.9 +/- 1.1 U/L (P less than 0.01), and the mean FSH levels decreased from 6.6 +/- 2.0 to 3.7 +/- 2.2 U/L (P less than 0.02). Pulsatile LH secretion before and during T treatment was studied in five subjects. Neither the mean nadir LH interval nor the LH pulse amplitude changed significantly in these five subjects. The serum T level in the woman with the androgen-secreting ovarian tumor was 9.6 nmol/L, and it declined to normal after removal of the tumor. Her mean serum LH and FSH levels, the mean nadir LH interval, and LH pulse amplitude were in the normal range before and after removal of the tumor. Studies of ovarian histopathology in 26 transsexual subjects after long term androgen treatment revealed multiple cystic follicles in 18 subjects (69.2%), diffuse ovarian stromal hyperplasia in 21 subjects (80.8%), collagenization of the tunica albuginea in 25 subjects (96.2%), and luteinization of stromal cells in 7 subjects (26.9%). Findings consistent with criteria for the pathological diagnosis of polycystic ovaries, that is 3 of the 4 findings listed above, were present in 18 of the 26 subjects (69.2%).(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2471710     DOI: 10.1210/jcem-69-1-151

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  29 in total

1.  Ovarian stimulation outcomes among transgender men compared with fertile cisgender women.

Authors:  Hadar Amir; Iris Yaish; Nivin Samara; Joseph Hasson; Asnat Groutz; Foad Azem
Journal:  J Assist Reprod Genet       Date:  2020-07-28       Impact factor: 3.412

Review 2.  The ovarian stroma as a new frontier.

Authors:  Hadrian M Kinnear; Claire E Tomaszewski; Faith L Chang; Molly B Moravek; Min Xu; Vasantha Padmanabhan; Ariella Shikanov
Journal:  Reproduction       Date:  2020-09       Impact factor: 3.906

Review 3.  Fertility preservation options in transgender people: A review.

Authors:  Natnita Mattawanon; Jessica B Spencer; David A Schirmer; Vin Tangpricha
Journal:  Rev Endocr Metab Disord       Date:  2018-09       Impact factor: 6.514

4.  Oocyte cryopreservation among transmasculine youth: a case series.

Authors:  Diane Chen; Lia A Bernardi; Mary Ellen Pavone; Eve C Feinberg; Molly B Moravek
Journal:  J Assist Reprod Genet       Date:  2018-08-22       Impact factor: 3.412

5.  Formative development of a fertility decision aid for transgender adolescents and young adults: a multidisciplinary Delphi consensus study.

Authors:  Victoria D Kolbuck; Afiya Sajwani; Moira A Kyweluk; Courtney Finlayson; Elisa J Gordon; Diane Chen
Journal:  J Assist Reprod Genet       Date:  2020-09-30       Impact factor: 3.412

Review 6.  Impact of Exogenous Testosterone on Reproduction in Transgender Men.

Authors:  Molly B Moravek; Hadrian M Kinnear; Jenny George; Jourdin Batchelor; Ariella Shikanov; Vasantha Padmanabhan; John F Randolph
Journal:  Endocrinology       Date:  2020-03-01       Impact factor: 4.736

7.  Oocyte retrieval outcomes among adolescent transgender males.

Authors:  Hadar Amir; Asaf Oren; Emilie Klochendler Frishman; Onit Sapir; Yoel Shufaro; Anat Segev Becker; Foad Azem; Avi Ben-Haroush
Journal:  J Assist Reprod Genet       Date:  2020-05-20       Impact factor: 3.412

8.  Rapid occurrence of thelarche and menarche induced by hydrocortisone in a teenage girl with previously untreated congenital adrenal hyperplasia.

Authors:  H P Schwarz; A Jocham; U Kuhnle
Journal:  Eur J Pediatr       Date:  1995-08       Impact factor: 3.183

Review 9.  Hypersecretion of luteinizing hormone in the polycystic ovary syndrome and a novel hormone 'gonadotrophin surge attenuating factor'.

Authors:  A H Balen
Journal:  J R Soc Med       Date:  1995-06       Impact factor: 5.344

10.  Subfertile female androgen receptor knockout mice exhibit defects in neuroendocrine signaling, intraovarian function, and uterine development but not uterine function.

Authors:  K A Walters; K J McTavish; M G Seneviratne; M Jimenez; A C McMahon; C M Allan; L A Salamonsen; D J Handelsman
Journal:  Endocrinology       Date:  2009-04-09       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.